Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Epizyme, Inc.
  6. Financials
    EPZM   US29428V1044

EPIZYME, INC.

(EPZM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 4882 2401 103506--
Entreprise Value (EV)1 2471 895959410301171
P/E ratio -3,58x-12,7x-4,74x-2,26x-2,73x-3,59x
Yield ------
Capitalization / Revenue 22,5x94,1x70,0x9,49x6,76x3,64x
EV / Revenue 11,4x79,6x60,9x7,68x4,02x1,23x
EV / EBITDA -1,95x-10,8x-4,33x-1,90x-1,38x-0,87x
Price to Book 2,09x7,26x5,97x3,21x2,02x1,37x
Nbr of stocks (in thousands) 79 16891 074101 581102 250--
Reference price (USD) 6,1624,610,94,954,954,95
Announcement Date 02/26/201902/24/202002/23/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 21,723,815,853,474,8139
EBITDA1 -127-176-221-216-219-196
Operating profit (EBIT)1 -128-177-225-209-203-171
Operating Margin -590%-744%-1 430%-392%-272%-123%
Pre-Tax Profit (EBT)1 -124-170-232-225-212-176
Net income1 -124-173-232-225-212-176
Net margin -570%-728%-1 470%-422%-283%-126%
EPS2 -1,72-1,93-2,29-2,19-1,81-1,38
Dividend per Share ------
Announcement Date 02/26/201902/24/202002/23/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 8,387,6313,08,3626,110,0
EBITDA ------
Operating profit (EBIT)1 -62,1-64,3-58,2-51,7-32,4-51,8
Operating Margin -742%-843%-448%-618%-124%-518%
Pre-Tax Profit (EBT)1 -66,1-70,3-64,4-54,6-35,5-54,3
Net income1 -66,2-70,3-64,4-54,6-35,5-54,3
Net margin -791%-921%-495%-653%-136%-543%
EPS2 -0,65-0,69-0,63-0,54-0,33-0,53
Dividend per Share ------
Announcement Date 02/23/202105/06/202108/09/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 24034514496,4205335
Leverage (Debt / EBITDA) 1,89x1,96x0,65x0,45x0,94x1,71x
Free Cash Flow ------
ROE (Net Profit / Equities) -52,8%-60,4%-89,8%-135%-96,4%-54,8%
Shareholders' equity1 234287258167220321
ROA (Net Profit / Asset) -43,8%-----
Assets1 282-----
Book Value Per Share2 2,943,391,821,542,453,62
Cash Flow per Share -1,69-----1,72
Capex --0,88---
Capex / Sales --5,58%---
Announcement Date 02/26/201902/24/202002/23/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 506 135 109
Net sales (USD) 15 762 000
Number of employees 304
Sales / Employee (USD) 51 849
Free-Float 80,9%
Free-Float capitalization (USD) 409 644 155
Avg. Exchange 20 sessions (USD) 3 433 547
Average Daily Capital Traded 0,68%
EPS & Dividend